Britain's nursing union cuts ties with Israeli pharma giant Teva over IDF ties
The Royal College of Nursing cited Teva's ties to the IDF and past legal sanctions in cutting ties with the drugmaker. Teva expressed disappointment and accused the union of politicizing Britain's health care system
The Royal College of Nursing (RCN), Britain's nursing union, has terminated its partnership with Israeli drugmaker Teva Pharmaceutical Industries due to concerns over Teva's connections to the Israel Defense Forces (IDF) and a history of corporate misconduct. The RCN announced it will no longer supply Teva's products and has cancelled its sponsorship of a migraine conference at the RCN's London headquarters.
Teva expressed disappointment with the decision, which it characterized as the politicization of Britain's healthcare system. Pro-Palestinian groups had lobbied the RCN to sever ties with Teva. Carmel O Boyle, chairwoman of the RCN's governing council, stated that after investigating Teva's activities, the union found some of them to be in conflict with its values.
Teva was fined €462.6 million by the European Commission in 2024 for restricting competitors from marketing their multiple sclerosis drugs and settled with the U.S. Justice Department in 2023 for $225 million related to price-fixing. Despite the decision, Teva remains committed to supporting healthcare professionals and patients in ensuring access to quality and affordable medicines.
Written by urgent.news from Haaretz's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- Royal College of Nursing cuts ties with Israeli drug company theguardian.com
